| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVNT | Common Stock | Options Exercise | $84,168 | +2,400 | +45% | $35.07 | 7,734 | 08 Jan 2024 | Direct | |
| transaction | AVNT | Common Stock | Disposed to Issuer | $87,073 | -2,259 | -29% | $38.54 | 5,475 | 08 Jan 2024 | Direct | |
| holding | AVNT | Common Stock | 28,073 | 08 Jan 2024 | Supplemental Plan | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AVNT | Stock Appreciation Rights | Options Exercise | $0 | -2,400 | -100% | $0.000000* | 0 | 08 Jan 2024 | Common Stock | 2,400 | $35.07 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The information in this report is based on a plan statement as of January 8, 2024. |
| F2 | SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $35.07 per share and no more than one-third of the grant can vest per year during the first three years. |